期刊文献+

系统性红斑狼疮肾损伤患者血清CRP、血尿酸和免疫球蛋白水平的变化及意义 被引量:21

Changes of serum CRP,serum uric acid and immunoglobulin in patients with renal damage of systemic lupus erythematosus
下载PDF
导出
摘要 目的:观察系统性红斑狼疮(systemic lupus erythematosus,SLE)肾损伤患者血清C反应蛋白(CRP)、血尿酸和免疫球蛋白(IgG、IgA和IgM)的表达水平,探讨其在SLE肾损伤患者中的临床应用价值。方法:将收治的95例SLE患者按照狼疮肾炎(lupus nephritis,LN)诊断标准分为狼疮肾炎组(LN组,n=64)和非狼疮肾炎组(NLN组,n=31),另选取35例健康体检者为正常对照组。治疗前采集所有受试者血液样本,用ELISA法检测血清CRP和血尿酸浓度,并同步用免疫透射比浊法检测血清免疫球蛋白的水平,分析检测结果。结果:SLE组患者血清CRP和血尿酸水平均显著高于正常对照组(P<0.05);其中,SLE患者LN组血清CRP和血尿酸水平均显著高于NLN组和正常对照组(P<0.05);SLE患者NLN组血清CRP水平显著高于正常对照组(P<0.05);NLN组血尿酸水平略高于正常对照组,但比较差异无统计学意义(P>0.05)。SLE组患者血清免疫球蛋白水平高于正常对照组(P<0.05);其中,SLE患者LN组血清免疫球蛋白IgG、IgA和IgM水平均显著高于NLN组和正常对照组(P<0.05);SLE患者NLN组血清免疫球蛋白IgG、IgA和IgM水平均高于正常对照组,比较差异有统计学意义(P<0.05)。结论:SLE肾损伤患者体液免疫被不同程度地激活,B细胞功能亢进,全身炎症反应严重,肾脏存在不同程度受损;血清CRP、血尿酸和免疫球蛋白(IgG、IgA和IgM)可能参与了SLE肾损伤病理过程,是早期诊断的参考指标。 Objective:To observe the expression of serum CRP,serum uric acid and immunoglobulin(IgG,IgA and IgM)in patients with renal damage of systemic lupus erythematosus,and to explore their clinical application value.Methods:A total of 95 patients with SLE were divided into lupus nephritis group(LN group,n=64)and non-lupus nephritis group(NLN group,n=31)according to the diagnostic criteria of lupus nephritis.Besides,35 healthy subjects were selected as normal control group.Blood samples were collected from all subjects before treatment.Serum CRP and serum uric acid concentrations were measured by ELISA.The levels of serum immunoglobulins were detected by immunoturbidimetry.Finally,the results were analyzed statistically.Results:The levels of serum CRP and serum uric acid in patients with SLE were significantly higher than those in NLN group and normal control group(P0.05).The levels of serum CRP and serum uric acid in LN group of SLE patients were significantly higher than those in NLN group and normal control group(P0.05).The serum CRP level in NLN group was significantly higher than that in normal control group(P0.05).The serum uric acid level of NLN group was slightly higher than that of the control group,but the difference was not statistically significant(P0.05).The level of serum immunoglobulin in SLE group was higher than that in normal control group(P0.05).The levels of serum immunoglobulin IgG,IgA and IgM in LN group of SLE patients were significantly higher than those in NLN group and normal control group(P0.05).The levels of serum immunoglobulin IgG,IgA and IgM in NLN group of SLE patients were significantly higher than those in normal control group(P0.05).Conclusions:The humoral immunity of patients with SLE renal injury was activated,with B-cell hyperthyroidism,severe systemic inflammatory response and kidney damage to varying degrees.Serum CRP,serum uric acid and immunoglobulin(IgG,IgA and IgM)may be involved in SLE renal injury pathological process,and they are the reference indicators for the early diagnosis of systemic lupus erythematosus.
作者 龙君
出处 《海南医学院学报》 CAS 2017年第16期2218-2220,2224,共4页 Journal of Hainan Medical University
基金 四川省卫生厅科研课题(125678)~~
关键词 系统性红斑狼疮 肾损伤 C反应蛋白 血尿酸 免疫球蛋白 Systemic lupus erythematosus Renal injury C-reactive protein Uric acid Immunoglobulin
  • 相关文献

参考文献5

二级参考文献48

  • 1Cameron J. Lupus nephritis [ J ]. J Am Soc Nephrol, 1999,10:413- 424.
  • 2Weening J, D Agati V, Schwartz M, et al. The classification of glomerulonephritis in systemic lupus erythematousus revisited [ J ]. Kidney Int,2004,65:521-530.
  • 3Gordon C ,Jayne D, Pusey C, et al. European consensus statement on the terminology used in the management of lupus glomerulonephfitis [ J]. Lupus,2009,18:257 - 263.
  • 4Bertsias G, Ioannidis JPA, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics[ J]. Ann Rheum Dis,2008, 67 : 195- 205.
  • 5Boumpas D, Sidiropoulos P, Bertsias G. Optimum therapeutic approanhes for lupus nephritis:what therapy and for whom? [J]. Nat Clin Pract Rheumatol,2005 ,1:22- 30.
  • 6Austin H. Lupus membranous nephropathy:eontrolled trial of prednisone,pulse eyclophosphamide and eyclosporine A [J]. J Am Soc Nephrol,2004,15:54A.
  • 7Borba E, Guedes L, Christmann R, et al. Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria [ J ] Rheumatol Int,2006,26 : 1078- 1083.
  • 8Tse K,Lam M,Tang S,et al. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinurla resistant to angiotensin inhibition or blockade [ J ]. Lupus, 2007,16 :d6- 51.
  • 9McDonald S, Russ G. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand [J]. Nephrol Dial Transplant, 2002, 17 2212- 2219.
  • 10Moroni G, Tantardini F, Ponticelli C. Renal replacement therapy in lupus nephritis[ J]. J Nephrol,2003 ,16 :787- 791.

共引文献588

同被引文献223

引证文献21

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部